Enter generative AI, which the pharma industry is adopting at a terrific rate. By ingesting and analysing vast biological ...
The worlds of technology and entrepreneurship are captivated by recent advances in generative AI and large language models (LLMs). But if the future has arrived, as science fiction writer William ...
In today’s digitally transformed world, technology plays a critical role in how pharmaceutical companies do business. From drug discovery to manufacturing and commercialization, technology is powering ...
The specialty pharmacy industry is in a state of transformation, fueled by the rise of complex, innovative therapies and the critical need for more robust patient support. For too long, specialty ...
Agentic AI promises autonomous workflow management but struggles with proprietary data gaps in pharma. Most pharmaceutical companies use retrieval augmented generation (RAG) due to cost barriers of ...
When Pfizer PFE (NYSE: PFE) acquired Biohaven Pharmaceutical Holding Company Ltd., the maker of a portfolio of calcitonin gene-related peptide (CGRP) receptor antagonists such as Nurtec ODT ...
Akums Drugs & Pharma and Sharda University signed an MoU to collaborate on pharma research, technology transfer, skill ...
Novo Nordisk was a pioneer in developing GLP-1 drugs for metabolic disorders, but its products are still mainly once-weekly injections. The Danish pharmaceutical giant is putting up $285 million to ...
EssilorLuxottica and Meta have unveiled the second generation of smart glasses, featuring live-streaming and AI applications. Better numbers in EssilorLuxottica's pharma division thanks to Stelles ...
DUBLIN--(BUSINESS WIRE)--The "Royalty Rates in Pharmaceutical and Biotechnology Deals" report has been added to ResearchAndMarkets.com's offering. Royalty Rates in Pharmaceutical and Biotechnology ...
NEW YORK, Feb. 20, 2025 /PRNewswire/ -- Hong Kong Pharma Digital Technology Holdings Limited has recently signed a cooperation agreement with a leading technology-driven e-commerce platform serving ...